Observing the Clinical Course of Duchenne Muscular Dystrophy in Medicaid Real-World Healthcare Data
ConclusionsThis study is the first to use diagnosis and procedure codes from real-world Medicaid claims to document the clinical course in DMD. Findings were consistent with previously published estimates from commercially insured populations and clinical registries; and contribute to the expanding body of real-world evidence around clinical progression of patients with DMD.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Back Curves | Brain | Cardiology | Cardiovascular | Drugs & Pharmacology | Health Insurance | Heart | Insurance | Medicaid | Muscular Dystrophy | Neurology | Reflex Sympathetic Dystrophy | Respiratory Medicine | Scoliosis | Study